Georgia Tech Neuro Seminar Series

“Modulation of Pathways with Deep Brain Stimulation”

This event will be hosted both in-person and virtually.  Join the talk virtually here.  

Matthew Johnson, Ph.D. 
Professor and Institute for Translational Neuroscience Scholar
Department of Biomedical Engineering
University of Minnesota

Recent advances in neurotechnology for basic science research and healthcare have created new and exciting opportunities to interface with our nervous system.  Deep brain stimulation (DBS) is one such technology that has enabled numerous people living with movement disorders reclaim control over their motor function. A deeper understanding of the neural pathways and physiological mechanisms underlying DBS therapy continues to be critically important to improve efficacy and decrease variability of the treatment.  This seminar will first highlight our preclinical efforts to understand how modulating neural pathways with DBS affects information encoding within and external to the basal ganglia and in turn how that relates to changes in motor signs of Parkinson’s disease. The seminar will also cover how subject-specific computational modeling and optimization theory can enable prospective identification of therapeutic DBS settings in individuals with Parkinson’s disease.

Dr. Johnson is a Professor of Biomedical Engineering and Associate Director of the Earl E. Bakken Medical Devices Center at the University of Minnesota. Dr. Johnson’s expertise is in the area of translational neural engineering with specific research interests in studying how the brain responds and adapts to deep brain stimulation therapies and in developing devices and algorithms to more precisely and efficiently treat disorders of the nervous system. He currently serves as a director of the NeuroTech Course, which seeks to educate innovators in how to translate and commercialize neurotechnology.